Marathon Runners With Type 1 Diabetes
Assessment of Physical Capacity and Metabolic Parameters in Marathon Runners With Type 1 Diabetes: an Observational Study
2 other identifiers
observational
10
1 country
1
Brief Summary
The goal of this observational study is to learn about the physical capacity and metabolic characteristics of male marathon runners with type 1 diabetes mellitus (T1DM). The main question it aims to answer is: Do male marathon runners with T1DM have different physical fitness and metabolic profiles compared to healthy runners without diabetes? Participants with T1DM and healthy controls who have completed a marathon will undergo a single in-person assessment, including body composition analysis, resting metabolic rate measurement, and a maximal exercise test
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 22, 2023
CompletedFirst Submitted
Initial submission to the registry
April 13, 2025
CompletedFirst Posted
Study publicly available on registry
April 20, 2025
CompletedApril 20, 2025
April 1, 2025
2 months
April 13, 2025
April 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VO₂max (mL/kg/min)
peak oxygen uptake during graded exercise testing
single visit
Secondary Outcomes (6)
Resting metabolic rate (kcal/day)
single visit
Body adipose percentage [%]
single visit
Lean tissue percentage [%]
single visit
Forced Vital Capacity [L]
single visit
Maximum Vital Capacity [L]
single visit
- +1 more secondary outcomes
Study Arms (2)
Type 1 diabetes group
Male participants with confirmed T1DM diagnosis for ≥1 year who have completed a marathon.
Control Group
Healthy male marathon runners matched by age, sex, and training background
Eligibility Criteria
Adult marathon runners aged ≥18 years. Participants in the T1DM group with a confirmed diagnosis of T1DM for at least one year. The control group comprises healthy people with similar physical activity levels but no chronic health conditions.
You may qualify if:
- A diagnosis of T1DM for at least 1 year.
- Age ≥ 18 years.
- Written informed consent and adherence to the study protocol.
You may not qualify if:
- Pregnancy.
- Use of medications significantly affecting metabolism or exercise performance
- Presence of chronic medical or psychiatric conditions limiting safe participation
- Presence of advanced chronic complications of diabetes: proliferative retinopathy, diabetic kidney disease in stages III-V, cardiovascular diseases
- Inability to safely complete maximal exercise testing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences
Poznan, Greater Poland Voivodeship, 60-834, Poland
Related Publications (7)
Shepherd JA, Ng BK, Sommer MJ, Heymsfield SB. Body composition by DXA. Bone. 2017 Nov;104:101-105. doi: 10.1016/j.bone.2017.06.010. Epub 2017 Jun 16.
PMID: 28625918BACKGROUNDAchamrah N, Delsoglio M, De Waele E, Berger MM, Pichard C. Indirect calorimetry: The 6 main issues. Clin Nutr. 2021 Jan;40(1):4-14. doi: 10.1016/j.clnu.2020.06.024. Epub 2020 Jul 2.
PMID: 32709554BACKGROUNDPoole DC, Wilkerson DP, Jones AM. Validity of criteria for establishing maximal O2 uptake during ramp exercise tests. Eur J Appl Physiol. 2008 Mar;102(4):403-10. doi: 10.1007/s00421-007-0596-3. Epub 2007 Oct 30.
PMID: 17968581BACKGROUNDThuillier P, Domun N, Sonnet E, Le Ven F, Roudaut C, Kergus A, Kerlan V, Roudaut N. Prevention of exercise-induced hypoglycemia in 12 patients with type 1 diabetes running the Paris Marathon using continuous glucose monitoring: A prospective, single-center observational study. Diabetes Metab. 2022 Mar;48(2):101321. doi: 10.1016/j.diabet.2022.101321. Epub 2022 Jan 12.
PMID: 35032674BACKGROUNDGrimm JJ, Muchnick S. Type I diabetes and marathon running. Diabetes Care. 1993 Dec;16(12):1624. doi: 10.2337/diacare.16.12.1624a. No abstract available.
PMID: 8299461BACKGROUNDRiddell MC, Scott SN, Fournier PA, Colberg SR, Gallen IW, Moser O, Stettler C, Yardley JE, Zaharieva DP, Adolfsson P, Bracken RM. The competitive athlete with type 1 diabetes. Diabetologia. 2020 Aug;63(8):1475-1490. doi: 10.1007/s00125-020-05183-8. Epub 2020 Jun 12.
PMID: 32533229BACKGROUNDChimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P. What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia. 2012 Mar;55(3):542-51. doi: 10.1007/s00125-011-2403-2. Epub 2011 Dec 22.
PMID: 22189486BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dorota Zozulinska-Ziolkiewicz, MD, PhD
Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Internal Medicine and Diabetology
Study Record Dates
First Submitted
April 13, 2025
First Posted
April 20, 2025
Study Start
August 30, 2023
Primary Completion
October 22, 2023
Study Completion
October 22, 2023
Last Updated
April 20, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared due to the small sample size and the potential risk of participant re-identification, even with de-identified data. The study was not designed with broad data sharing in mind, and no participant consent was obtained for public data release.